Workflow
颖泰生物(833819) - 2023 Q4 - 年度业绩
NutrichemNutrichem(BJ:833819)2024-02-25 16:00

Financial Performance - The company's operating revenue for 2023 is approximately ¥5.91 billion, a decrease of 27.64% compared to the previous year[4] - The net profit attributable to shareholders is approximately ¥95.09 million, down 91.00% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses is approximately ¥60.30 million, a decline of 94.40% compared to the previous year[4] - Basic earnings per share are estimated at ¥0.08, a decrease of 90.70% from the previous year[4] Assets and Equity - Total assets at the end of the reporting period are approximately ¥12.54 billion, a slight decrease of 0.03% from the beginning of the period[5] - Shareholders' equity attributable to the company is approximately ¥5.79 billion, down 2.22% from the beginning of the period[5] - The net asset per share attributable to shareholders is estimated at ¥4.72, a decrease of 2.28% from the beginning of the period[5] Performance Factors - The significant decline in performance is attributed to factors such as reduced downstream customer demand, industry destocking, and intensified market competition[7] - Despite efforts to leverage collaborative advantages in production and sales, the company's performance was still impacted[8] Financial Reporting - The financial data presented is preliminary and has not been audited, with final figures to be disclosed in the annual report[9]